These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11516779)
1. Nasal vaccination using live bacterial vectors. Mielcarek N; Alonso S; Locht C Adv Drug Deliv Rev; 2001 Sep; 51(1-3):55-69. PubMed ID: 11516779 [TBL] [Abstract][Full Text] [Related]
2. Live bacterial delivery systems for development of mucosal vaccines. Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657 [TBL] [Abstract][Full Text] [Related]
3. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route. Li R; Lim A; Alonso S Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832 [TBL] [Abstract][Full Text] [Related]
4. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582 [TBL] [Abstract][Full Text] [Related]
5. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726 [TBL] [Abstract][Full Text] [Related]
6. Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e. Li R; Lim A; Ow ST; Phoon MC; Locht C; Chow VT; Alonso S Vaccine; 2011 Jul; 29(33):5502-11. PubMed ID: 21624415 [TBL] [Abstract][Full Text] [Related]
7. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Mielcarek N; Debrie AS; Raze D; Quatannens J; Engle J; Goldman WE; Locht C Vaccine; 2006 Apr; 24 Suppl 2():S2-54-5. PubMed ID: 16823926 [TBL] [Abstract][Full Text] [Related]
8. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
9. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255 [TBL] [Abstract][Full Text] [Related]
12. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Lagranderie M; Murray A; Gicquel B; Leclerc C; Gheorghiu M Vaccine; 1993 Oct; 11(13):1283-90. PubMed ID: 8296480 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens. Hormaeche CE J Immunol Methods; 1991 Aug; 142(1):113-20. PubMed ID: 1919015 [TBL] [Abstract][Full Text] [Related]
15. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900 [TBL] [Abstract][Full Text] [Related]
16. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646 [TBL] [Abstract][Full Text] [Related]
17. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375 [TBL] [Abstract][Full Text] [Related]